Immune thrombocytopenic purpura
Information
- Disease name
- Immune thrombocytopenic purpura
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03395210 | Active, not recruiting | Phase 2 | A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP) | March 22, 2018 | December 31, 2025 |
| NCT00168038 | Completed | Phase 3 | Treatment of Chronic Immune Thrombocytopenic Purpura (ITP) With Intravenous Immunoglobulin IgPro10 | December 2004 | February 2006 |
| NCT00376077 | Completed | Phase 3 | A Randomized Study of IVIG vs. IVIG With High Dose Methylprednisolone in Childhood ITP. | August 2005 | April 2016 |
| NCT00426270 | Completed | Phase 3 | Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in Adults | June 2006 | September 2008 |
| NCT00621894 | Completed | Phase 2 | Oral LGD-4665 Versus Placebo in Adults With Immune Thrombocytopenic Purpura (ITP) for 6 Weeks Plus Open Treatment Continuation | March 1, 2008 | May 1, 2009 |
| NCT00718692 | Completed | Phase 2 | Open Label Trial on the Safety and Efficacy of Sym001 in the Treatment of Immune Thrombocytopenic Purpura (ITP) | July 2008 | October 2011 |
| NCT00774202 | Completed | Phase 2/Phase 3 | Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITP | November 2003 | February 2008 |
| NCT01107951 | Completed | Phase 2 | Low-dose Rituximab and High-dose Dexamethasone as First Line Treatment for ITP | April 2010 | January 2013 |
| NCT00005570 | Completed | An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers | April 2000 | July 2000 | |
| NCT01719692 | Completed | N/A | Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia | October 2012 | February 2016 |
| NCT01730352 | Completed | Phase 2/Phase 3 | Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients | October 2008 | March 2012 |
| NCT02076399 | Completed | Phase 3 | A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) | July 14, 2014 | April 21, 2016 |
| NCT02076412 | Completed | Phase 3 | A Efficacy and Safety Study of Fostamatinib in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) | January 2015 | August 2016 |
| NCT02077192 | Completed | Phase 3 | Open Label Study of R788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP) | October 2014 | June 2, 2020 |
| NCT02085993 | Completed | Study of Patients With ITP Estimating the Proportion Administering Romiplostim Correctly After Receiving Home Administration Training | July 2014 | November 2015 | |
| NCT02273960 | Completed | Phase 1/Phase 2 | Study to Evaluate Safety and Efficacy in Adult Subjects With ITP | November 17, 2014 | January 22, 2018 |
| NCT04056507 | Completed | Immunological Markers in Adult Patients With Immune Thrombocytopenic Purpura | April 12, 2012 | September 30, 2015 | |
| NCT04057703 | Completed | Balance Benefit / Risk of Immunomodulatory Treatments at the Child and Adolescent for Autoimmune Cytopenia. | January 18, 2016 | December 4, 2016 | |
| NCT04070599 | Completed | Phase 3 | Initial Hemato-immunological Profile on the Evolution of Immunological Thrombopenic Purpura. | April 12, 2011 | March 5, 2014 |
| NCT01390649 | Completed | Phase 4 | A Safety Study of Intravenous Immunoglobulin in Patients With Chronic Immune Thrombocytopenic Purpura (ITP) | November 2011 | September 2014 |
| NCT01439321 | Completed | Outcomes Comparison of Chronic Immune Thrombocytopenic Purpura (ITP) Patients Switched to Eltrombopag and Romiplostim | November 2010 | June 2011 | |
| NCT01510873 | Completed | Health-related Quality of Life and Fatigue in Adult Patients With Primary Immune Thrombocytopenic Purpura (pITP) | December 2011 | January 2014 | |
| NCT01621204 | Completed | Phase 3 | A Trial of Eltrombopag or Intravenous Immune Globulin Before Surgery for Immune Thrombocytopenia Patients | October 2012 | August 2019 |
| NCT01652599 | Completed | Phase 2 | Eltrombopag and High-dose Dexamethasone as First Line Treatment for IT | June 2012 | November 2013 |
| NCT01668615 | Completed | Efficacy of Immunomudulatory Therapy With All-trans Retinoid Acid for Adults With Chronic Immune Thrombocytopenia | January 2011 | August 2012 | |
| NCT01672151 | Completed | Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia | November 2011 | August 2012 | |
| NCT01713855 | Completed | N/A | Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura | October 2004 | March 2006 |
| NCT03363334 | No longer available | Expanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITP | |||
| NCT06444477 | Not yet recruiting | Molecular Analysis of Thrombocytopenia and Cancer (MATAC): Investigating Antigenic Mimicry Between Platelets and Tumor Cells in Patients With Immune Thrombocytopenia (ITP) Associated With Cancer | June 2024 | December 2024 | |
| NCT05585944 | Not yet recruiting | N/A | " Effect of Single-nucleotide Polymorphism of CD40 Gene rs1883832 C/T on the Risk of Immune Thrombocytopenic Purpura " | November 1, 2022 | May 1, 2023 |
| NCT05835050 | Not yet recruiting | N/A | Assessment of Serum interleukin10 Level in Patients With Immune Thrombocytopenic Purpura at Sohag University Hospital | May 2023 | October 2024 |
| NCT04323748 | Recruiting | Phase 1 | Dose Dense Rituximab for High Risk Newly Diagnosed Acute Immune Thrombocytopenic Purpura | February 24, 2021 | July 31, 2025 |
| NCT00991939 | Terminated | Phase 3 | Initial Treatment of Patients With Immune Thrombocytopenic Purpura | January 2010 | March 2013 |
| NCT03177629 | Unknown status | Phase 3 | H. Pylori Eradication for Moderate ITP | May 23, 2017 | December 2020 |
| NCT01255332 | Unknown status | Helicobacter Pylori Immune Thrombocytopenic Purpura | September 2010 | August 2012 | |
| NCT05093257 | Unknown status | Study of T Cells and Natural Killer Cells Expression in Patients With Immune Thrombocytopenic Purpura | November 2021 | December 2022 | |
| NCT01609452 | Withdrawn | Phase 2/Phase 3 | MONICA-SC: A Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in Subjects With ITP | December 2015 |
- OrphaNumber from OrphaNet (Orphanet)
- 3002